{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T15:26:10Z","timestamp":1780413970404,"version":"3.54.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012895","name":"Zoetis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012895","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Ancylostomatids (\u2018hookworms\u2019) are among the most important zoonotic nematode parasites infecting dogs worldwide.<jats:italic>Ancylostoma caninum<\/jats:italic>and<jats:italic>Uncinaria stenocephala<\/jats:italic>are two of the most common hookworm species that infect dogs. Both immature and adult stages of hookworms are voracious blood feeders and can cause death in young dogs before infection can be detected by routine fecal examination. Hence, treatment of both immature and adult stages of hookworms will decrease the risk of important clinical disease in the dog as well as the environmental contamination caused by egg-laying adults, which should reduce the risk of infection for both dogs and humans. The studies presented here were conducted to evaluate the efficacy of a novel, oral chewable tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio\u2122), against induced larval (L<jats:sub>4<\/jats:sub>), immature adult (L<jats:sub>5<\/jats:sub>) and adult<jats:italic>A. caninum<\/jats:italic>, and adult<jats:italic>U. stenocephala<\/jats:italic>infections in dogs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Eight negative-controlled, masked, randomized laboratory studies were conducted. Two separate studies were conducted against each of the target parasites and stages. Sixteen or 18 purpose bred dogs, 8 or 9 in each of the two treatment groups, were included in each study. Dogs experimentally infected with the target parasite were dosed once on Day 0 with either placebo tablets or Simparica Trio\u2122 tablets to provide minimum dosages of 1.2\u00a0mg\/kg sarolaner, 24\u00a0\u00b5g\/kg moxidectin and 5.0\u00a0mg\/kg pyrantel (as pamoate salt). Timing of dosing relative to parasite inoculation allowed for efficacy to be evaluated primarily against the target parasite stage. Worm counts were conducted 7 or 8 days after treatments during necropsy. Efficacy was based on the number of worms recovered at necropsy compared to placebo control.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Based on geometric mean worm counts, efficacy of Simparica Trio\u2122 was \u2265 98.4% against L<jats:sub>4<\/jats:sub>larval stage of<jats:italic>A. caninum<\/jats:italic>, \u2265 99.8% against immature adult (L<jats:sub>5<\/jats:sub>)<jats:italic>A. caninum<\/jats:italic>, and 100% against adult<jats:italic>A. caninum<\/jats:italic>and adult<jats:italic>U. stenocephala.<\/jats:italic><\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>These studies confirm the efficacy of a single oral dose of a novel, chewable tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio\u2122) against L<jats:sub>4<\/jats:sub>larval and immature adult (L<jats:sub>5<\/jats:sub>)<jats:italic>A. caninum<\/jats:italic>, and adult<jats:italic>A. caninum<\/jats:italic>and<jats:italic>U. stenocephala<\/jats:italic>infections in dogs.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13071-020-3951-4","type":"journal-article","created":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:03:04Z","timestamp":1583020984000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Efficacy of Simparica Trio\u2122, a novel chewable tablet containing sarolaner, moxidectin and pyrantel, against induced hookworm infections in dogs"],"prefix":"10.1186","volume":"13","author":[{"given":"Csilla","family":"Becskei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjan","family":"Thys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Kryda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Martorell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Geurden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leentje","family":"Dreesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiago","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean P.","family":"Mahabir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,1]]},"reference":[{"key":"3951_CR1","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.pt.2010.01.005","volume":"4","author":"DD Bowman","year":"2010","unstructured":"Bowman DD, Montgomery SP, Zajac AM, Eberhard ML, Kazacos KR. Hookworms of dogs and cats as agents of cutaneous larva migrans. Trends Parasitol. 2010;4:162\u20137.","journal-title":"Trends Parasitol."},{"key":"3951_CR2","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/1756-3305-5-91","volume":"5","author":"D Traversa","year":"2012","unstructured":"Traversa D. Pet roundworms and hookworms: a continuing need for global worming. Parasites Vectors. 2012;5:91.","journal-title":"Parasites Vectors."},{"key":"3951_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.vetpar.2006.08.004","volume":"143","author":"FJ Mart\u00ednez-Moreno","year":"2007","unstructured":"Mart\u00ednez-Moreno FJ, Hern\u00e1ndez S, L\u00f3pez-Cobos E, Becerra C, Acosta I, Mart\u00ednez-Moreno A. Estimation of canine intestinal parasites in C\u00f3rdoba (Spain) and their risk to public health. Vet Parasitol. 2007;143:7\u201313.","journal-title":"Vet Parasitol."},{"key":"3951_CR4","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/S0195-5616(87)50005-5","volume":"17","author":"UP Kalkofen","year":"1987","unstructured":"Kalkofen UP. Hookworms of dogs and cats. Vet Clin N Am Small Anim Pract. 1987;17:1341\u201354.","journal-title":"Vet Clin N Am Small Anim Pract."},{"key":"3951_CR5","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/0014-4894(82)90039-X","volume":"54","author":"GA Schad","year":"1982","unstructured":"Schad GA, Page MR. Ancylostoma caninum: adult worm removal, corticosteroid treatment, and resumed development of arrested larvae in dogs. Exp Parasitol. 1982;54:303\u20139.","journal-title":"Exp Parasitol."},{"key":"3951_CR6","unstructured":"Companion Animal Parasite Council. CAPC guideline on hookworms for dogs; 2016. https:\/\/capcvet.org\/guidelines\/hookworms\/. Accessed 12 May 2019."},{"key":"3951_CR7","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/0304-4017(94)90110-4","volume":"52","author":"DE Jacobs","year":"1994","unstructured":"Jacobs DE, Arakawa A, Courtney CH, Gemmell MA, McCall JW, Myers GH, et al. World Association for the Advancement of Veterinary Parasitology (W.A.A.V.P.) guidelines for evaluating the efficacy of anthelmintics for dogs and cats. Vet Parasitol. 1994;52:179\u2013202.","journal-title":"Vet Parasitol."},{"key":"3951_CR8","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S0304-4017(00)00443-X","volume":"96","author":"J Vercruysse","year":"2001","unstructured":"Vercruysse J, Holdsworth P, Letonja T, Barth D, Conder G, Hamamoto K, et al. International harmonisation of anthelmintic efficacy guidelines. Vet Parasitol. 2001;96:171\u201393.","journal-title":"Vet Parasitol."},{"key":"3951_CR9","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0304-4017(01)00615-X","volume":"103","author":"J Vercruysse","year":"2002","unstructured":"Vercruysse J, Holdsworth P, Letonja T, Conder G, Hamamoto K, Okano K, et al. International harmonisation of anthelmintic efficacy guidelines (Part 2). Vet Parasitol. 2002;103:277\u201397.","journal-title":"Vet Parasitol."},{"key":"3951_CR10","unstructured":"Directive 2010\/63\/EU of the European Parliament and of the Council of 22 September 2010 on the protection of animals used for scientific purposes.https:\/\/eur-lex.europa.eu\/LexUriServ\/LexUriServ.do?uri=OJ:L:2010:276:0033:0079:EN:PDF. Accessed 12 Sept 2019."},{"key":"3951_CR11","unstructured":"USDA Animal Welfare Act and Regulations. https:\/\/www.aphis.usda.gov\/animal_welfare\/downloads\/bluebook-ac-awa.pdf. Accessed 12 Sept 2019."},{"key":"3951_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-020-3950-5","author":"C Becskei","year":"2020","unstructured":"Becskei C, Kryda K, Thys M, Holzmer S, Bowersock L, Fernandes T, et al. Efficacy of a new oral chewable tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio\u2122) against induced ascarid infections in dogs. Parasites Vectors. 2020. https:\/\/doi.org\/10.1186\/s13071-020-3950-5.","journal-title":"Parasites Vectors."},{"key":"3951_CR13","first-page":"15","volume":"6","author":"MW Dryden","year":"2005","unstructured":"Dryden MW, Payne PA, Ridley R, Smith V. Comparison of common fecal flotation techniques for the recovery of parasite eggs and oocysts. Vet Ther. 2005;6:15\u201328.","journal-title":"Vet Ther."},{"key":"3951_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-020-3947-0","author":"C Becskei","year":"2020","unstructured":"Becskei C, Kryda K, Fias D, Follis SL, Wozniakiewicz M, Mahabir SP, et al. Field efficacy and safety of a novel oral chewable tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio\u2122) against naturally acquired gastrointestinal nematode infections in dogs presented as veterinary patients in Europe and the USA. Parasites Vectors. 2020. https:\/\/doi.org\/10.1186\/s13071-020-3947-0.","journal-title":"Parasites Vectors."},{"key":"3951_CR15","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2460\/ajvr.1991.52.01.64","volume":"52","author":"DD Bowman","year":"1991","unstructured":"Bowman DD, Lin DS, Johnson RC, Hepler DI. Effects of milbemycin oxime on adult Ancylostoma caninum and Uncinaria stenocephala in dogs with experimentally induced infections. Am J Vet Res. 1991;52:64.","journal-title":"Am J Vet Res."},{"key":"3951_CR16","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.vetpar.2015.12.032","volume":"217","author":"S Rehbein","year":"2016","unstructured":"Rehbein S, Dorr P, Bowman DD, Crafford D, Kusi I, Postoli R, et al. Efficacy of afoxolaner plus milbemycin oxime chewable tablets against naturally acquired intestinal nematodes in dogs. Vet Parasitol. 2016;217:29\u201335.","journal-title":"Vet Parasitol."},{"key":"3951_CR17","first-page":"297","volume":"63","author":"LA Menelaos","year":"2006","unstructured":"Menelaos LA, Smaragda KE. Prevalence of hookworm parasites in dog from the area of Thessaloniki and their zoonotic importance. Bull USAMV-CN. 2006;63:297\u2013303.","journal-title":"Bull USAMV-CN"},{"key":"3951_CR18","first-page":"790","volume":"161","author":"IP Wright","year":"2007","unstructured":"Wright IP, Wolfe A. Prevalence of zoonotic nematode species in dogs in Lancashire. Vet Rec. 2007;161:790.","journal-title":"Vet Rec."},{"key":"3951_CR19","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1017\/S0031182018002020","volume":"146","author":"A Garcia-Campos","year":"2019","unstructured":"Garcia-Campos A, Power C, O\u02bcShaughnessy J, Browne C, Lawlor A, McCarthy G, et al. One-year parasitological screening of stray dogs and cats in County Dublin, Ireland. Parasitology. 2019;146:746\u201352.","journal-title":"Parasitology"},{"key":"3951_CR20","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1186\/s13071-019-3702-6","volume":"12","author":"K Kryda","year":"2019","unstructured":"Kryda K, Six RH, Walsh KF, Holzmer SJ, Chapin S, Mahabir SP, et al. Laboratory and field studies to investigate the efficacy of a novel, orally administered combination product containing sarolaner, moxidectin and pyrantel for the prevention of heartworm disease (Dirofilaria immitis) in dogs. Parasites Vectors. 2019;12:445.","journal-title":"Parasites Vectors."},{"key":"3951_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-020-3948-z","author":"C Becskei","year":"2020","unstructured":"Becskei C, Thys M, Doherty P, Mahabir SP. Efficacy of orally administered combination of moxidectin, sarolaner and pyrantel (Simparica Trio\u2122) for the prevention of experimental Angiostrongylus vasorum infection in dogs. Parasit Vectors. 2020;. https:\/\/doi.org\/10.1186\/s13071-020-3948-z.","journal-title":"Parasit Vectors."},{"key":"3951_CR22","unstructured":"Companion Animal Parasite Council. CAPC guideline on fleas for dogs; 2017. https:\/\/capcvet.org\/guidelines\/fleas\/. Accessed 12 May 2019."},{"key":"3951_CR23","unstructured":"Companion Animal Parasite Council. CAPC guideline on ticks for dogs; 2017. https:\/\/capcvet.org\/guidelines\/ticks\/. Accessed 12 May 2019."},{"key":"3951_CR24","unstructured":"European Scientific Counsel Companion Animal Parasites. ESCCAP Guideline 5: Control of vector-borne diseases in dogs and cats, 3rd edn; 2019. https:\/\/www.esccap.org\/uploads\/docs\/znkh6j1d_0775_ESCCAP_Guideline_GL5_v8_1p.pdf Accessed 30 Jan 2020."},{"key":"3951_CR25","unstructured":"European Scientific Counsel Companion Animal Parasites. ESCCAP Guideline 3: control of ectoparasites in dogs and cats, 6th ed; 2018. https:\/\/www.esccap.org\/uploads\/docs\/mjy50wev_0720_ESCCAP_Guideline_GL3_v9_1p.pdf. Accessed 30 Jan 2020."},{"key":"3951_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-020-3952-3","author":"K Kryda","year":"2020","unstructured":"Kryda K, Mahabir SP, Inskeep T, Rugg J. Efficacy and safety of a novel oral chewable combination tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio\u2122) against fleas on dogs presented as veterinary patients in the USA. Parasites Vectors. 2020. https:\/\/doi.org\/10.1186\/s13071-020-3952-3.","journal-title":"Parasites Vectors."},{"key":"3951_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-020-3946-1","author":"C Becskei","year":"2020","unstructured":"Becskei C, Fias D, Mahabir SP, Farkas R. Efficacy of a novel oral chewable tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio\u2122) against natural flea and tick infestations on dogs presented as veterinary patients in Europe. Parasites Vectors. 2020. https:\/\/doi.org\/10.1186\/s13071-020-3946-1.","journal-title":"Parasites Vectors."},{"key":"3951_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-020-3944-3","author":"K Kryda","year":"2020","unstructured":"Kryda K, Mahabir SP, Carter L, Everett WR, Young DR, Meyer L, et al. Laboratory studies evaluating the efficacy of a novel orally administered combination of sarolaner, moxidectin and pyrantel (Simparica Trio\u2122) for the treatment and control of flea infestations on dogs. Parasites Vectors. 2020. https:\/\/doi.org\/10.1186\/s13071-020-3944-3.","journal-title":"Parasites Vectors."},{"key":"3951_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-020-3945-2","author":"K Kryda","year":"2020","unstructured":"Kryda K, Mahabir SP, Chapin S, Holzmer SJ, Bowersock L, Everett WR, et al. Efficacy of a novel orally administered combination product containing sarolaner, moxidectin and pyrantel (Simparica Trio\u2122) against induced infestations of five common tick species infesting dogs in the USA. Parasites Vectors. 2020. https:\/\/doi.org\/10.1186\/s13071-020-3945-2.","journal-title":"Parasites Vectors."},{"key":"3951_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-020-3949-y","author":"C Becskei","year":"2020","unstructured":"Becskei C, Liebenberg C, Thys M, Mahabir SP. Efficacy of a novel combination tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio\u2122) against four common tick species infesting dogs in Europe. Parasit Vectors. 2020. https:\/\/doi.org\/10.1186\/s13071-020-3949-y.","journal-title":"Parasit Vectors."}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-020-3951-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13071-020-3951-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-020-3951-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T10:57:39Z","timestamp":1722509859000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-020-3951-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["3951"],"URL":"https:\/\/doi.org\/10.1186\/s13071-020-3951-4","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,1]]},"assertion":[{"value":"19 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The protocols were reviewed and approved by the study sites\u2019 Institutional Animal Care and Use Committee prior to implementation.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This study was funded by Zoetis, Parsippany, NJ, USA. CB, KK, MT, SM, TG, LD, TF and SPM were employees of Zoetis. LM was contracted study investigator.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"99"}}